These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
338 related items for PubMed ID: 6188568
1. Current perspectives of neuroimmunologic disease: multiple sclerosis and experimental allergic encephalomyelitis (1,2). Paterson PY, Day ED. Clin Immunol Rev; ; 1(4):581-697. PubMed ID: 6188568 [No Abstract] [Full Text] [Related]
2. Conclusion: is myelin basic protein the right antigen and experimental allergic encephalomyelitis the right model for multiple sclerosis? Alvord EC. Prog Clin Biol Res; 1984; 146():503-8. PubMed ID: 6201920 [No Abstract] [Full Text] [Related]
3. A morphologic comparison of three experimental models of experimental allergic encephalomyelitis with multiple sclerosis. Shaw CM, Alvord EC. Prog Clin Biol Res; 1984; 146():61-6. PubMed ID: 6201924 [No Abstract] [Full Text] [Related]
4. Induction of experimental autoimmune encephalomyelitis in Lewis rats by a viral peptide with limited homology to myelin basic protein. Mao YS, Lu CZ, Wang X, Xiao BG. Exp Neurol; 2007 Aug; 206(2):231-9. PubMed ID: 17617406 [Abstract] [Full Text] [Related]
5. Immunologic determinants of experimental neurologic autoimmune disease and approaches to the multiple sclerosis problem. Paterson PY, Fujinami RS, Day ED, Varitek VA, Pescovitz MD, Kelly J, Lorand L. Trans Am Clin Climatol Assoc; 1978 Aug; 89():109-18. PubMed ID: 81557 [No Abstract] [Full Text] [Related]
6. Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis. Raine CS. Lab Invest; 1984 Jun; 50(6):608-35. PubMed ID: 6202955 [No Abstract] [Full Text] [Related]
8. Multiple sclerosis: immunopathologic mechanisms in the progression and resolution of inflammatory demyelination. Raine CS. Res Publ Assoc Res Nerv Ment Dis; 1990 Mar; 68():37-54. PubMed ID: 1691521 [No Abstract] [Full Text] [Related]
10. [Division of neuroimmunologic diseases. Foundation, principles, and classification]. Meyer-Rienecker H. Nervenarzt; 1976 Jul; 47(7):429-34. PubMed ID: 183159 [No Abstract] [Full Text] [Related]
11. Relationship of experimental allergic encephalomyelitis to human disease. Levine S. Res Publ Assoc Res Nerv Ment Dis; 1971 Jul; 49():33-49. PubMed ID: 5002492 [No Abstract] [Full Text] [Related]
14. Neuroimmunology of multiple sclerosis and experimental allergic encephalomyelitis. Stuerzebecher S, Martin R. Neuroimaging Clin N Am; 2000 Nov 17; 10(4):649-68 ,vii-viii. PubMed ID: 11359717 [Abstract] [Full Text] [Related]
15. Exacerbation of protracted-relapsing experimental allergic encephalomyelitis in DA rats by gluten-free diet. Di Marco R, Mangano K, Quattrocchi C, Amato F, Nicoletti F, Buschard K. APMIS; 2004 Oct 17; 112(10):651-5. PubMed ID: 15601316 [Abstract] [Full Text] [Related]
16. Susceptibility to experimental allergic encephalomyelitis in animal models of autoimmunity. Lublin FD. Curr Opin Neurol Neurosurg; 1992 Apr 17; 5(2):182-7. PubMed ID: 1377972 [Abstract] [Full Text] [Related]
18. Immunospecific therapy of central nervous system autoaggression with an antigen-specific T cell line. Wekerle H. Prog Clin Biol Res; 1984 May 17; 146():435-41. PubMed ID: 6201913 [No Abstract] [Full Text] [Related]
19. Joseph E. Smadel Memorial Lecture: neuroimmunologic diseases of animals and humans. Paterson PY. Rev Infect Dis; 1979 May 17; 1(3):469-82. PubMed ID: 95235 [Abstract] [Full Text] [Related]
20. Multiple sclerosis: autoimmune disease. Chinen A, Yokoyama M. Hawaii Med J; 1971 May 17; 30(6):464-71. PubMed ID: 5156962 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]